Anti-Nerve Growth Factor in Pain Management: Current Evidence

Journal of Pain Research - New Zealand
doi 10.2147/jpr.s89061
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Novel Nerve Growth Factor-Targeting Theranostics for Osteoarthritis Pain Management

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Evidence for Pro- -Nerve Growth Factor, a Biosynthetic Precursor to -Nerve Growth Factor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1977English

Nerve Growth Factor and Galantamine Ameliorate Early Signs of Neurodegeneration in Anti-Nerve Growth Factor Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Temporal Mismatch Between Pain Behaviour, Skin Nerve Growth Factor and Intra-Epidermal Nerve Fibre Density in Trigeminal Neuropathic Pain

BMC Neuroscience
NeuroscienceCellularMolecular Neuroscience
2014English

Nerve Growth Factor

Nature
Multidisciplinary
1973English

Nerve Growth Factor‐induced Muscle Hyperalgesia Facilitates Ischemic Contraction‐evoked Pain

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2019English

Nerve Growth Factor Increases Insulin Secretion and Barium Current in Pancreatic -Cells

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2001English

Sonic Hedgehog Signaling Pathway Promotes Pancreatic Cancer Pain via Nerve Growth Factor

Regional Anesthesia and Pain Medicine
MedicineAnesthesiologyPain Medicine
2019English

Tapentadol in the Management of Cancer Pain: Current Evidence and Future Perspectives

Journal of Pain Research
AnesthesiologyPain Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy